This is a working overview of Thiol, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-08-01. Anything still debated is marked as such rather than presented as settled.
Glutathione supports several cellular processes beyond direct antioxidant action. It serves as a cofactor for glutathione peroxidase and glutathione S-transferase enzymes, which reduce peroxides and conjugate electrophiles, respectively. The molecule also acts as a reservoir of cysteine, an amino acid that can limit protein synthesis and redox signaling. In human nutrition, oral glutathione is sold as a supplement, but how much intact glutathione reaches tissues after ingestion remains an active research question. Clinical claims about supplementation are not uniformly supported by controlled trials.
Glutathione is a small tripeptide built from glutamic acid, cysteine, and glycine. Its peptide bond between glutamate and cysteine involves the gamma-carboxyl group rather than the usual alpha-carboxyl group. This structure gives the molecule a reactive thiol on the cysteine residue. The reduced form, often abbreviated GSH, is the predominant intracellular species in many cell types. Because the thiol can donate electrons, glutathione participates in redox chemistry and in the conjugation of reactive molecules.
Cells synthesize glutathione through two ATP-dependent steps: glutamate-cysteine ligase joins glutamate and cysteine, and glutathione synthetase adds glycine to form the complete tripeptide. Breakdown occurs through gamma-glutamyl transpeptidase and subsequent peptidase reactions, forming the gamma-glutamyl cycle. Within cells, glutathione also forms a disulfide-linked dimer called GSSG when two GSH molecules react. The balance between GSH and GSSG is widely used as an indicator of oxidative conditions, although the ratio can vary by compartment and tissue.
In cells, glutathione exists mainly in a reduced form called GSH. When two GSH molecules react, they form oxidized glutathione, or GSSG, which contains a disulfide bond. The ratio of GSH to GSSG is often used as an indicator of oxidative stress. Enzymes such as glutathione peroxidase and glutathione reductase help cycle the molecule between these two states. This cycling supports antioxidant defense, detoxification of reactive molecules, and regulation of certain signaling pathways.
Glutathione is present in most tissues, with especially high concentrations in the liver. It also serves as a cofactor for some enzymes and helps transport amino acids across cell membranes. In plants and microorganisms, glutathione contributes to stress responses and metal handling. The molecule is synthesized in two ATP-dependent steps, first producing gamma-glutamylcysteine and then adding glycine. Because cysteine availability often limits synthesis, dietary and metabolic factors can influence glutathione levels. Research continues to examine how these levels relate to health and disease.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C10H17N3O6S | Reduced form; oxidized dimer is C20H32N6O12S2 |
| Molar mass | 307.32 g/mol | For reduced glutathione (GSH) |
| Appearance | White crystalline powder | Typical laboratory and supplement-grade material |
| Solubility | Soluble in water | Poorly soluble in ethanol and other nonpolar solvents |
| Typical storage | -20 C, desiccated, protected from light | Reduced form can oxidize in solution |
Glutathione supports detoxification by conjugating reactive electrophiles through glutathione S-transferases. The resulting conjugates are processed and exported, often after further metabolism. It also stores cysteine, transports amino acids across membranes through the gamma-glutamyl cycle, and assists in the maturation of iron-sulfur clusters and some prostaglandins. In plants, animals, and many microbes, the molecule appears in similar roles, but concentrations vary enormously between tissues. Liver, kidney, and red blood cells tend to contain high amounts, while blood plasma contains much less.
Glutathione is a small tripeptide built from glutamate, cysteine, and glycine. The peptide bond between glutamate and cysteine uses the gamma-carboxyl group, a linkage that resists ordinary peptidases. Cells make it in two ATP-dependent steps: gamma-glutamylcysteine synthetase joins glutamate and cysteine, then glutathione synthetase adds glycine. The pathway is feedback-inhibited by glutathione itself, so intracellular levels tend to stay within a narrow range. Because cysteine is often limiting, sulfur amino acid supply influences how much glutathione a cell can produce.
Interpreting glutathione measurements requires attention to pre-analytical variables. The GSSG concentration in a sample can rise artificially during storage or processing, making the GSH/GSSG ratio unreliable if not controlled. Reference ranges vary by specimen type, assay, and population, so comparisons across studies are difficult. Plasma glutathione is low and sensitive to hemolysis, while whole blood reflects primarily erythrocyte content. Many studies measure total glutathione rather than the reduced and oxidized forms separately, which limits conclusions about redox status.
Accurate measurement of glutathione begins with careful sample handling. Because GSH oxidizes rapidly to GSSG, samples must be processed quickly or frozen immediately. Acid precipitation with metaphosphoric acid or perchloric acid is common; it lowers pH, precipitates proteins, and helps preserve the reduced form. Chelating agents such as EDTA can limit metal-catalyzed oxidation. For whole blood, hemolysis releases glutathione from erythrocytes, so plasma and serum values differ substantially from whole blood values.
Carbon dioxide is colorless. At low concentrations, the gas is odorless; however, at sufficiently high concentrations, it has a sharp, acidic odor. At standard temperature and pressure, the density of carbon dioxide is around 1.98 kg/m3, about 1.53 times that of air. Carbon dioxide has no liquid state at pressures below 0.51795(10) MPa (5.11177(99) atm). At a pressure of 1 atm (0.101325 MPa), the gas deposits directly to a solid at temperatures below 194.6855(30) K (−78.4645(30) °C) and the solid sublimes directly to a gas above this temperature. In its solid state, carbon dioxide is commonly called dry ice.
== Clinical studies == Randomized trials have evaluated Dexcom systems as part of real-time CGM-based diabetes management. In the 2020 MILLENNIALS crossover trial, participants aged 16–24 years with type 1 diabetes used the Dexcom G6 for eight weeks and conventional self-monitoring of blood glucose for eight weeks. During G6 use, the mean percentage of time in the target glucose range of 70–180 mg/dL was 35.7%, compared with 24.6% during self-monitoring, and mean glycated hemoglobin (HbA1c) was 0.76 percentage points lower. The 2021 MOBILE trial randomly assigned 175 adults with poorly controlled type 2 diabetes, treated with basal insulin but not mealtime insulin, to use either the G6 or a conventional blood glucose meter for eight months. HbA1c decreased by 1.1 percentage points in the G6 group and by 0.6 points in the meter group; after adjustment, the between-group difference was 0.4 percentage points. Mean time in the 70–180 mg/dL range was 59% with the G6 and 43% with meter monitoring, while one participant in each group experienced severe hypoglycemia. The study and devices were funded by Dexcom, and a Dexcom employee was among the authors. Both trials compared a CGM-enabled management strategy with fingerstick-based monitoring; they did not compare the G6 with another CGM system.
=== Cell movement === Actin is also involved in cell movement. Several different types of protrusions mediated directly or indirectly by actin are involved in cell migration in different ways, with the most important ones being lamellipodia, filopodia, invadopodia and blebs.
Micromeritics is the science of the behavior of particulate materials smaller than 75 μm. It is thus the study of the fundamental and derived properties of individual as well as a collection of particles. Micromeritics involves materials with larger particles than nanoparticles where they are smaller than 0.1 μm. The knowledge and control of the size of particles has importance in pharmacy and materials science. The size, and hence the surface area of a particle, can be related to the physical, chemical and pharmacological properties of drugs. Clinically, the particle size of a drug can affect its release from dosage forms that are administered orally, parenterally, rectally and topically. The successful formulation of suspensions, emulsions and tablets; both physical stability and pharmacological response also depends on the particle size achieved in the product.
Sources: en.wikipedia.org
Naltrexone at a dose of 50 mg/day has been found to occupy approximately 90 to 95% of brain MORs and 20 to 35% of brain DORs. Naltrexone at a dose of 100 mg/day has been found to achieve 87% and 92% brain occupancy of the KOR in different studies. Per simulation, a lower dose of naltrexone of 25 mg/day might be expected to achieve around 60% brain occupancy of the KOR but still close to 90% occupancy of the MOR. In a study of the duration of MOR blockade with naltrexone, the drug with a single 50 mg dose showed 91% blockade of brain [11C]carfentanil (a selective MOR ligand) binding at 48 hours (2 days), 80% blockade at 72 hours (3 days), 46% blockade at 120 hours (5 days), and 30% blockade at 168 hours (7 days). The half-time of brain MOR blockade by naltrexone in this study was 72 to 108 hours (3.0 to 4.5 days). Based on these findings, doses of naltrexone of even less than 50 mg/day would be expected to achieve virtually complete brain MOR occupancy. Blockade of brain MORs with naltrexone is much longer-lasting than with other opioid antagonists like naloxone (half-time of ~1.7 hours intranasally) or nalmefene (half-time of ~29 hours). The half-life of occupancy of the brain MOR and duration of clinical effect of naltrexone are much longer than suggested by its plasma elimination half-life. A single 50 mg oral dose of naltrexone has been found to block brain MORs and opioid effects for at least 48 to 72 hours.
=== Other === Organic polymers can be used to create aerogels. SEAgel is made of agar. Cellulose from plants can be used to create a flexible aerogel. GraPhage13 is the first graphene-based aerogel assembled using graphene oxide and the M13 bacteriophage. Chalcogel is an aerogel made of chalcogens (the column of elements on the periodic table beginning with oxygen) such as sulfur, selenium, and other elements. Metals less expensive than platinum have been used in its creation. Aerogels made of cadmium selenide quantum dots in a porous 3-D network have been developed for use in the semiconductor industry. Aerogel performance may be augmented for a specific application by the addition of dopants, reinforcing structures, and hybridizing compounds. For example, Spaceloft is a composite of aerogel with some kind of fibrous batting. Amyloid fibrils from food waste (whey) have the potential for use in AF aerogels for gold extraction from e-waste. Their use would have a less environmental impact than that of the conventional use of activated carbon as adsorbent.
=== Rediscovery of ancient treatments === Similar to the situation in malaria therapy, where successful treatments based on ancient recipes have been found, there has already been some success in finding and testing ancient drugs and other treatments that are effective against AMR bacteria.
Contraindications to light therapy for seasonal affective disorder include conditions that might render the eyes more vulnerable to phototoxicity, tendency toward mania, photosensitive skin conditions, or use of a photosensitizing herb (such as St. John's wort) or medication. Patients with porphyria should avoid most forms of light therapy. Patients on certain drugs such as methotrexate or chloroquine should use caution with light therapy as there is a chance that these drugs could cause porphyria. Side effects of light therapy for sleep phase disorders include jumpiness or jitteriness, headache, eye irritation and nausea. Some non-depressive physical complaints, such as poor vision and skin rash or irritation, may improve with light therapy.
=== Scraped surface generators === The world’s first patent for a slurry ice generator was filed by Sunwell Technologies Inc. of Canada in 1976. Sunwell Technologies Inc. introduced slurry ice under the trade name deepchill ice, in the late 1970s. Slurry ice is created through a process of forming spherical ice crystals within a liquid. The slurry ice generator is a scraped-surface vertical shell and tube heat exchanger. It consists of concentric tubes with refrigerant flowing between them and the water/freezing point depressant solution in the inner tube. The inner surface of the inner tube is wiped using a mechanism which in the original Sunwell design consists of a central shaft, spring-loaded plastic blades, bearings, and seals. The small ice crystals formed in the solution near the tube surface are wiped away from the surface and mixed with unfrozen water, forming the slurry. Other slurry ice generators adapted the first idea of wiping the surface using an auger originally designed to create flake ice. Wipers also can be brushes or fluidized bed heat exchangers for ice crystallization. In these heat exchangers, steel particles circulate with the fluid, mechanically removing the crystals from the surface. At the outlet, steel particles and slurry ice are separated.
Sources: en.wikipedia.org
It is a tripeptide of glutamic acid, cysteine, and glycine. The linkage between glutamate and cysteine uses the gamma-carboxyl group, which is unusual for peptides.
GSH is the reduced form with a free thiol group. GSSG is the oxidized dimer formed when two GSH molecules join by a disulfide bond.
It is synthesized inside cells and is not classified as an essential dietary nutrient for most people. Dietary and supplemental sources are studied, but direct requirements are not established in the same way as for vitamins.
Glutathione is a tripeptide made from glutamate, cysteine, and glycine. Its cysteine residue provides a thiol group that is central to its redox activity. The glutamate-cysteine bond forms through the gamma-carboxyl group of glutamate.